![James Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Hall
Directeur Général chez
Balticgruppen Bio AB
Health Technology
Profil
James Hall is Chief Executive Officer at Betagenon AB since 2021.
Formerly, Dr. Hall was Chief Executive Officer at Athera Biotechnologies AB from 2019 to 2021.
Dr. Hall also served as Chief Executive Officer at Amplifier TX AB.
Postes actifs de James Hall
| Sociétés | Poste | Début |
|---|---|---|
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Directeur Général | 01/05/2021 |
Anciens postes connus de James Hall
| Sociétés | Poste | Fin |
|---|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Directeur Général | 01/04/2021 |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Balticgruppen Bio AB
Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Health Technology |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Health Technology |
